391 related articles for article (PubMed ID: 30010131)
1. Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.
Padovani A; Benussi A; Cantoni V; Dell'Era V; Cotelli MS; Caratozzolo S; Turrone R; Rozzini L; Alberici A; Altomare D; Depari A; Flammini A; Frisoni GB; Borroni B
J Alzheimers Dis; 2018; 65(1):221-230. PubMed ID: 30010131
[TBL] [Abstract][Full Text] [Related]
2. Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy.
Padovani A; Benussi A; Cotelli MS; Ferrari C; Cantoni V; Dell'Era V; Turrone R; Paghera B; Borroni B
Alzheimers Res Ther; 2019 Dec; 11(1):95. PubMed ID: 31787103
[TBL] [Abstract][Full Text] [Related]
3. Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
Mimura Y; Nishida H; Nakajima S; Tsugawa S; Morita S; Yoshida K; Tarumi R; Ogyu K; Wada M; Kurose S; Miyazaki T; Blumberger DM; Daskalakis ZJ; Chen R; Mimura M; Noda Y
Neurosci Biobehav Rev; 2021 Feb; 121():47-59. PubMed ID: 33307047
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.
Schirinzi T; Di Lorenzo F; Sancesario GM; Di Lazzaro G; Ponzo V; Pisani A; Mercuri NB; Koch G; Martorana A
J Alzheimers Dis; 2018; 64(2):525-532. PubMed ID: 29914023
[TBL] [Abstract][Full Text] [Related]
5. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.
Alexopoulos P; Guo LH; Jiang M; Bujo H; Grimmer T; Förster S; Drzezga A; Kurz A; Perneczky R
J Alzheimers Dis; 2013; 36(2):401-8. PubMed ID: 23609762
[TBL] [Abstract][Full Text] [Related]
6. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia.
Benussi A; Di Lorenzo F; Dell'Era V; Cosseddu M; Alberici A; Caratozzolo S; Cotelli MS; Micheli A; Rozzini L; Depari A; Flammini A; Ponzo V; Martorana A; Caltagirone C; Padovani A; Koch G; Borroni B
Neurology; 2017 Aug; 89(7):665-672. PubMed ID: 28747446
[TBL] [Abstract][Full Text] [Related]
7. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
8. Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.
Hedderich DM; Spiro JE; Goldhardt O; Kaesmacher J; Wiestler B; Yakushev I; Zimmer C; Boeckh-Behrens T; Grimmer T
J Alzheimers Dis; 2018; 65(4):1459-1467. PubMed ID: 30175976
[TBL] [Abstract][Full Text] [Related]
9. LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment.
Di Lorenzo F; Motta C; Casula EP; Bonnì S; Assogna M; Caltagirone C; Martorana A; Koch G
Brain Stimul; 2020; 13(5):1175-1182. PubMed ID: 32485235
[TBL] [Abstract][Full Text] [Related]
10. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
12. Transcranial magnetic stimulation neurophysiology in patients with non-Alzheimer's neurodegenerative diseases: A systematic review and meta-analysis.
Mimura Y; Tobari Y; Nakahara K; Nakajima S; Yoshida K; Mimura M; Noda Y
Neurosci Biobehav Rev; 2023 Dec; 155():105451. PubMed ID: 37926239
[TBL] [Abstract][Full Text] [Related]
13. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
16. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment.
Nardone R; Bergmann J; Christova M; Caleri F; Tezzon F; Ladurner G; Trinka E; Golaszewski S
J Neural Transm (Vienna); 2012 Apr; 119(4):463-71. PubMed ID: 22016008
[TBL] [Abstract][Full Text] [Related]
17. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of atypical parkinsonisms with transcranial magnetic stimulation.
Benussi A; Dell'Era V; Cantoni V; Ferrari C; Caratozzolo S; Rozzini L; Alberici A; Padovani A; Borroni B
Brain Stimul; 2018; 11(2):366-373. PubMed ID: 29195744
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiological Correlates of Motor and Cognitive Dysfunction in Prodromal and Overt Dementia with Lewy Bodies.
Benussi A; Pilotto A; Cantoni V; Ferrari E; Borroni B; Padovani A
J Alzheimers Dis; 2022; 86(2):579-588. PubMed ID: 35094996
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
